Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Contineum Therapeutics Inc. Class A Common Stock
CTNM | US
12.41
USD-0.01
-0.08%
CTNM | US
Loading StockChartView...
About Contineum Therapeutics Inc. Class A Common Stock
Sector
US
Industry
US
Earnings date
30/06/2024
As of date
24/04/2026
Close
12.41
Open
12.57
High
12.57
Low
12.02
View Less
CTNM | US
Risk
50.5
Sharpe
1.65
Luna's Score
54/100
Recommendation
Hold
Luna says (CTNM | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
30.0%1 month
50.5%3 months
60.8%6 months
69.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.27
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
20.76
Ent. to rev.
8.25
PEG
-
Other Fundamentals
EBITDA
-38.42M
MarketCap
373.60M
MarketCap(USD)
373.60M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
20.60
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.68
Range1M
2.18
Range3M
4.53
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.56
Price X volume
1.72M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.76 | - | - |
| Ent. to Revenue | 8.25 | - | - |
| PE Ratio | - | - | - |
| Price to Book | 2.27 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 60.82 | - | - |
| Debt to Equity | 0.00 | - | - |
| Debt to Assets | 0.00 | - | - |
| Market Cap | 373.60M | - | - |
